Company Filing History:
Years Active: 1997-2009
Title: Janet E Mertz: Innovator in Breast Cancer Research
Introduction
Janet E Mertz is a prominent inventor based in Madison, WI (US). She has made significant contributions to the field of breast cancer research, holding a total of 4 patents. Her work focuses on utilizing estrogen-related receptors as biomarkers and therapeutic targets in breast cancer treatment.
Latest Patents
Among her latest patents, Mertz has developed methods for using estrogen-related receptor alpha (ERRα) status to determine prognosis, treatment strategy, and predisposition to breast cancer. This invention highlights ERRα as a crucial breast cancer biomarker, indicating that a high level of ERRα correlates with poor prognosis. By analyzing ERRα expression levels alongside the status of ERα and ErbB2, patients can make informed treatment choices. Additionally, her work on ERRα suggests that modulating its activity can be a viable treatment strategy for breast cancer.
Another significant patent involves the use of estrogen-related receptor gamma (ERRγ) status to determine prognosis and treatment strategies for breast cancer. ERRγ serves as both a biomarker and a treatment target, with high levels in breast cancer cells indicating a good prognosis. Mertz's research indicates that a high level of ERRγ in suspicious breast tissue can be indicative of breast cancer. By analyzing ERRγ status, patients can also make better treatment decisions, and decreasing ERRγ activity in cancer cells may provide a therapeutic avenue.
Career Highlights
Janet E Mertz is affiliated with the Wisconsin Alumni Research Foundation, where she continues her groundbreaking research. Her innovative approaches to breast cancer treatment have garnered attention and respect in the scientific community.
Collaborations
Mertz has collaborated with notable colleagues, including Xuedong Liu and Eric A Ariazi, to advance her research and develop effective treatment strategies for breast cancer.
Conclusion
Janet E Mertz's contributions to breast cancer research through her patents and collaborations have the potential to significantly impact treatment options for patients. Her work exemplifies the importance of innovation in the medical field, particularly in the fight against cancer.